USP4 expression levels in various normal and cancerous tissue types were further investigated by analysis of data from Oncomine, which revealed lower USP4 expression in multiple head and neck, breast, and lung cancers compared to matched normal tissues (Figure S1). This evidence concerns the gene USP4 and lung carcinoma.